気管支内ブロッカーの世界市場レポート2025-2031

QY Research > レポート一覧 > 医療機器と消耗材 > 気管支内ブロッカーの世界市場レポート2025-2031

英文タイトル： Global Endobronchial Blocker Market Outlook, In‑Depth Analysis & Forecast to 2031

レポートID：1491878
発表時期：2025-08-08
訪問回数：12
ページ数：149
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：131
レポートカテゴリ：医療機器と消耗材

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.70円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.70円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

本報告書は、気管支内ブロッカーの世界市場について、容量、生産量、収益、価格の概要を紹介します。2021年から2025年までの過去の市場収益/売上データ、2026年の予測データ、ならびに2032年までのCAGR（年平均成長率）予測を含む、世界市場動向の分析を提供します。本レポートは、メーカー、地域、製品種類、およびエンドユーザー産業の観点から、世界と主要地域の市場現状と将来性を研究したものです。世界と主要地域のトップメーカーを分析し、製品タイプおよびアプリケーション/エンドユーザー産業別に気管支内ブロッカー市場を分類しています。

本レポートでは、世界の気管支内ブロッカー市場の主要参加企業として、企業概要、販売数量、収益、価格、粗利益率、製品ポートフォリオ、地理的位置、主要な事業展開を以下のパラメータに基づいて紹介します。
本レポートは気管支内ブロッカーの主要生産者を調査するとともに、主要地域や国の消費状況も提供します。気管支内ブロッカーの主要地域／国における将来の市場ポテンシャルを重点的に分析し、それに基づき、異なるセグメントおよびサブセグメントにおける市場の将来動向を予測しております。アメリカ、カナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、その他の国々について、各国データおよび市場価値分析を提供しております。
2021年から2032年までの期間について、タイプ別および用途別の売上高、収益、価格に基づくセグメントデータを分析します。

本研究に含まれる主な企業は以下の通りです：
Teleflex
Cook
PROACT Medical
NexGen Medical
Fuji Systems
Well Lead Medical

タイプ別市場セグメント：
5Fr
7Fr
9Fr

用途別市場セグメント：
Hospital
Clinic
Others

地域別の市場セグメント：
北米
アジア太平洋
欧州
中南米
中東・アフリカ

本レポートの詳細内容：
世界の気管支内ブロッカー市場の現状と将来展望を包括的に分析し、グローバル主要地域における開発動向の綿密な調査を通じて、企業様に包括的な市場分析を提示します。市場の全体像を把握するため、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて気管支内ブロッカー市場を細分化しています。この分類と用途分析により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2021年から2026年までの実績と2032年までの予測として、メーカー別、地域別（地域レベル、国レベル）の気管支内ブロッカー生産量、成長率、市場シェアを調査しています。
二. 消費面では、気管支内ブロッカーの売上高について、地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2021年から2026年まで、および2032年までの予測を対象とします。
三. 主要メーカーの気管支内ブロッカー売上高、収益、市場シェア、業界ランキングについて、2021年から2026年までのデータに焦点を当てています。世界の気管支内ブロッカー市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づく競争状況と市場ポジショニングの分析を行います。
四. 本気管支内ブロッカーレポートは、関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立案するのに役立つ洞察を提供することを目的としています。売上高、成長動向、生産技術、用途、エンドユーザー産業に関する市場規模の詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。
章節目次：
第1章：気管支内ブロッカーレポートの範囲、市場セグメント（タイプ別、用途別など）ごとの市場規模、将来の発展可能性などをまとめたエグゼクティブサマリーをご紹介いたします。これにより、市場の最新状況を包括的に把握し、短期・中期・長期（2021-2032年）にわたる発展の見通しを把握いただけます。
第2章：気管支内ブロッカーの世界および主要生産者（地域／国別）の生産量／アウトプットについて分析します。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています（2021年～2032年）
第3章：気管支内ブロッカーの現在の市場状況を提示し、2032年までの世界的な収益・販売・生産を予測するとともに、消費量の多い地域と新興市場の成長要因を特定します（2021年～2032年）
第4章：気管支内ブロッカーメーカーの競争状況、価格、売上高、収益、市場シェア、業界ランキング、最新の開発計画、合併・買収情報など詳細に分析します（2021年～2026年）
第5章：気管支内ブロッカーの下流市場機会を特定し、用途別販売量・収益・価格設定を評価するとともに新興ユースケースを明らかにし、地域別・用途別の主要顧客をプロファイリングします
第6章：気管支内ブロッカーのグローバル生産能力、稼働率、市場シェア（2021-2032年）をマッピングし、効率的拠点を特定するとともに規制や貿易政策の影響とボトルネックを解明します
第7章：北米における気管支内ブロッカー市場をアプリケーション別・国別売上高・収益で分析し、主要メーカーをプロファイリングしつつ成長要因と障壁を評価します
第8章：欧州における気管支内ブロッカー市場をアプリケーション別・メーカー別に地域別売上高・収益・市場分析を行い、成長要因と障壁を明示します
第9章：アジア太平洋地域の気管支内ブロッカー市場を用途別・地域/国別の売上高と収益で定量化し、主要メーカーをプロファイリングするとともに高成長潜在地域を明らかにします
第10章：中南米における気管支内ブロッカー市場を用途別・国別売上高と収益で測定し、主要メーカーをプロファイリングするとともに投資機会と課題を特定します
第11章：中東・アフリカ地域の気管支内ブロッカー市場を用途別・国別に評価し、主要メーカーをプロファイリングするとともに投資見通しと市場障壁を概説します
第12章：気管支内ブロッカーの主要メーカーの概要を提供し、製品説明、売上高、収益、価格、粗利益率、最近の事業拡大などの情報を整理するとともに、SWOT分析および戦略動向分析を行います
第13章：気管支内ブロッカーのサプライチェーンを分析し、上流の原材料・供給業者、製造拠点と技術、コスト要因を明らかにします
第14章：気管支内ブロッカーの市場動向、最新動向、推進要因と制約要因、業界内のメーカーが直面する課題とリスク、関連する業界政策の分析を紹介します
第15章：レポートの要点と結論
第16章：付録

Description

The global Endobronchial Blocker market is projected to grow from US$ 7.2 million in 2024 to US$ 9.1 million by 2031, at a CAGR of 3.5% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

An endobronchial blocker is a medical device used during certain surgical procedures or critical care situations to selectively block one lung's airway while allowing ventilation of the other lung. It is often used in procedures like thoracic surgeries, lung isolation during one-lung ventilation, or to manage conditions where differential lung ventilation is necessary. The endobronchial blocker is typically placed through a bronchoscope and positioned in the main bronchus of the target lung to occlude the airflow to that lung. This allows the healthcare provider to control the ventilation and airflow to each lung independently, optimizing oxygenation and ventilation during the procedure.

North America key players of Endobronchial Blocker include Cook, Teleflex, Well Lead Medical, etc. The top three players hold a share about 72%. America is the largest market, and has a share about 72%. In terms of product type, 7Fr is the largest segment, accounting for a share of 41%. In terms of application, Hospital is the largest field with a share about 76 percent.

Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Endobronchial Blocker market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation
By Company
Teleflex
Cook
PROACT Medical
NexGen Medical
Fuji Systems
Well Lead Medical

Segment by Type
5Fr
7Fr
9Fr

Segment by Application
Hospital
Clinic
Others

Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
India
Europe
Germany
France
U.K.
Italy
Russia
Central South America
Brazil
Argentina

Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa

Chapter Outline
Chapter 1: Defines the Endobronchial Blocker study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).

Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.

Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).

Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).

Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

Table of Contents

1 Study Coverage
1.1 Introduction to Endobronchial Blocker: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Endobronchial Blocker Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 5Fr
1.2.3 7Fr
1.2.4 9Fr
1.3 Market Segmentation by Application
1.3.1 Global Endobronchial Blocker Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Endobronchial Blocker Revenue Estimates and Forecasts 2020-2031
2.2 Global Endobronchial Blocker Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Endobronchial Blocker Sales Estimates and Forecasts 2020-2031
2.4 Global Endobronchial Blocker Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers
3.1 Global Endobronchial Blocker Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Endobronchial Blocker Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 5Fr Market Size by Manufacturers
3.5.2 7Fr Market Size by Manufacturers
3.5.3 9Fr Market Size by Manufacturers
3.6 Global Endobronchial Blocker Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis
4.1 Global Endobronchial Blocker Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Endobronchial Blocker Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats

5 Global Downstream Application Analysis
5.1 Global Endobronchial Blocker Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Endobronchial Blocker Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Endobronchial Blocker Sales and Revenue by Type (2020-2031)
6.4 North America Endobronchial Blocker Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Endobronchial Blocker Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Endobronchial Blocker Sales and Revenue by Type (2020-2031)
7.4 Europe Endobronchial Blocker Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Endobronchial Blocker Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Endobronchial Blocker Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Endobronchial Blocker Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Endobronchial Blocker Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Endobronchial Blocker Sales and Revenue by Type (2020-2031)
9.4 Central and South America Endobronchial Blocker Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Endobronchial Blocker Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Endobronchial Blocker Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Endobronchial Blocker Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Endobronchial Blocker Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa

11 Corporate Profile
11.1 Teleflex
11.1.1 Teleflex Corporation Information
11.1.2 Teleflex Business Overview
11.1.3 Teleflex Endobronchial Blocker Product Models, Descriptions and Specifications
11.1.4 Teleflex Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Teleflex Endobronchial Blocker Sales by Product in 2024
11.1.6 Teleflex Endobronchial Blocker Sales by Application in 2024
11.1.7 Teleflex Endobronchial Blocker Sales by Geographic Area in 2024
11.1.8 Teleflex Endobronchial Blocker SWOT Analysis
11.1.9 Teleflex Recent Developments
11.2 Cook
11.2.1 Cook Corporation Information
11.2.2 Cook Business Overview
11.2.3 Cook Endobronchial Blocker Product Models, Descriptions and Specifications
11.2.4 Cook Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Cook Endobronchial Blocker Sales by Product in 2024
11.2.6 Cook Endobronchial Blocker Sales by Application in 2024
11.2.7 Cook Endobronchial Blocker Sales by Geographic Area in 2024
11.2.8 Cook Endobronchial Blocker SWOT Analysis
11.2.9 Cook Recent Developments
11.3 PROACT Medical
11.3.1 PROACT Medical Corporation Information
11.3.2 PROACT Medical Business Overview
11.3.3 PROACT Medical Endobronchial Blocker Product Models, Descriptions and Specifications
11.3.4 PROACT Medical Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 PROACT Medical Endobronchial Blocker Sales by Product in 2024
11.3.6 PROACT Medical Endobronchial Blocker Sales by Application in 2024
11.3.7 PROACT Medical Endobronchial Blocker Sales by Geographic Area in 2024
11.3.8 PROACT Medical Endobronchial Blocker SWOT Analysis
11.3.9 PROACT Medical Recent Developments
11.4 NexGen Medical
11.4.1 NexGen Medical Corporation Information
11.4.2 NexGen Medical Business Overview
11.4.3 NexGen Medical Endobronchial Blocker Product Models, Descriptions and Specifications
11.4.4 NexGen Medical Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 NexGen Medical Endobronchial Blocker Sales by Product in 2024
11.4.6 NexGen Medical Endobronchial Blocker Sales by Application in 2024
11.4.7 NexGen Medical Endobronchial Blocker Sales by Geographic Area in 2024
11.4.8 NexGen Medical Endobronchial Blocker SWOT Analysis
11.4.9 NexGen Medical Recent Developments
11.5 Fuji Systems
11.5.1 Fuji Systems Corporation Information
11.5.2 Fuji Systems Business Overview
11.5.3 Fuji Systems Endobronchial Blocker Product Models, Descriptions and Specifications
11.5.4 Fuji Systems Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Fuji Systems Endobronchial Blocker Sales by Product in 2024
11.5.6 Fuji Systems Endobronchial Blocker Sales by Application in 2024
11.5.7 Fuji Systems Endobronchial Blocker Sales by Geographic Area in 2024
11.5.8 Fuji Systems Endobronchial Blocker SWOT Analysis
11.5.9 Fuji Systems Recent Developments
11.6 Well Lead Medical
11.6.1 Well Lead Medical Corporation Information
11.6.2 Well Lead Medical Business Overview
11.6.3 Well Lead Medical Endobronchial Blocker Product Models, Descriptions and Specifications
11.6.4 Well Lead Medical Endobronchial Blocker Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Well Lead Medical Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Endobronchial Blocker Industry Chain
12.2 Endobronchial Blocker Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Endobronchial Blocker Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Endobronchial Blocker Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Endobronchial Blocker Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Endobronchial Blocker Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

Table of Figures

List of Tables
 Table 1. Global Endobronchial Blocker Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Endobronchial Blocker Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Endobronchial Blocker Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Endobronchial Blocker Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Endobronchial Blocker Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Endobronchial Blocker Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Units)
 Table 7. Global Endobronchial Blocker Sales by Region (2020-2025) & (Units)
 Table 8. Global Endobronchial Blocker Sales by Region (2026-2031) & (Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Endobronchial Blocker Sales by Manufacturers (2020-2025) & (Units)
 Table 11. Global Endobronchial Blocker Sales Share by Manufacturers (2020-2025)
 Table 12. Global Endobronchial Blocker Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Endobronchial Blocker Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Endobronchial Blocker by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endobronchial Blocker as of 2024)
 Table 16. Global Endobronchial Blocker Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Endobronchial Blocker Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Endobronchial Blocker Manufacturing Base and Headquarters
 Table 19. Global Endobronchial Blocker Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Endobronchial Blocker Sales by Type (2020-2025) & (Units)
 Table 23. Global Endobronchial Blocker Sales by Type (2026-2031) & (Units)
 Table 24. Global Endobronchial Blocker Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Endobronchial Blocker Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Endobronchial Blocker ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Endobronchial Blocker Sales by Application (2020-2025) & (Units)
 Table 29. Global Endobronchial Blocker Sales by Application (2026-2031) & (Units)
 Table 30. Endobronchial Blocker High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Endobronchial Blocker Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Endobronchial Blocker Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Endobronchial Blocker ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Endobronchial Blocker Growth Accelerators and Market Barriers
 Table 37. North America Endobronchial Blocker Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Endobronchial Blocker Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Endobronchial Blocker Growth Accelerators and Market Barriers
 Table 40. Europe Endobronchial Blocker Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Endobronchial Blocker Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Endobronchial Blocker Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Endobronchial Blocker Sales (Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Endobronchial Blocker Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Endobronchial Blocker Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Endobronchial Blocker Investment Opportunities and Key Challenges
 Table 47. Central and South America Endobronchial Blocker Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Endobronchial Blocker Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Endobronchial Blocker Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Teleflex Corporation Information
 Table 51. Teleflex Description and Major Businesses
 Table 52. Teleflex Product Models, Descriptions and Specifications
 Table 53. Teleflex Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Teleflex Sales Value Proportion by Product in 2024
 Table 55. Teleflex Sales Value Proportion by Application in 2024
 Table 56. Teleflex Sales Value Proportion by Geographic Area in 2024
 Table 57. Teleflex Endobronchial Blocker SWOT Analysis
 Table 58. Teleflex Recent Developments
 Table 59. Cook Corporation Information
 Table 60. Cook Description and Major Businesses
 Table 61. Cook Product Models, Descriptions and Specifications
 Table 62. Cook Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Cook Sales Value Proportion by Product in 2024
 Table 64. Cook Sales Value Proportion by Application in 2024
 Table 65. Cook Sales Value Proportion by Geographic Area in 2024
 Table 66. Cook Endobronchial Blocker SWOT Analysis
 Table 67. Cook Recent Developments
 Table 68. PROACT Medical Corporation Information
 Table 69. PROACT Medical Description and Major Businesses
 Table 70. PROACT Medical Product Models, Descriptions and Specifications
 Table 71. PROACT Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. PROACT Medical Sales Value Proportion by Product in 2024
 Table 73. PROACT Medical Sales Value Proportion by Application in 2024
 Table 74. PROACT Medical Sales Value Proportion by Geographic Area in 2024
 Table 75. PROACT Medical Endobronchial Blocker SWOT Analysis
 Table 76. PROACT Medical Recent Developments
 Table 77. NexGen Medical Corporation Information
 Table 78. NexGen Medical Description and Major Businesses
 Table 79. NexGen Medical Product Models, Descriptions and Specifications
 Table 80. NexGen Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 81. NexGen Medical Sales Value Proportion by Product in 2024
 Table 82. NexGen Medical Sales Value Proportion by Application in 2024
 Table 83. NexGen Medical Sales Value Proportion by Geographic Area in 2024
 Table 84. NexGen Medical Endobronchial Blocker SWOT Analysis
 Table 85. NexGen Medical Recent Developments
 Table 86. Fuji Systems Corporation Information
 Table 87. Fuji Systems Description and Major Businesses
 Table 88. Fuji Systems Product Models, Descriptions and Specifications
 Table 89. Fuji Systems Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 90. Fuji Systems Sales Value Proportion by Product in 2024
 Table 91. Fuji Systems Sales Value Proportion by Application in 2024
 Table 92. Fuji Systems Sales Value Proportion by Geographic Area in 2024
 Table 93. Fuji Systems Endobronchial Blocker SWOT Analysis
 Table 94. Fuji Systems Recent Developments
 Table 95. Well Lead Medical Corporation Information
 Table 96. Well Lead Medical Description and Major Businesses
 Table 97. Well Lead Medical Product Models, Descriptions and Specifications
 Table 98. Well Lead Medical Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 99. Well Lead Medical Recent Developments
 Table 100. Key Raw Materials Distribution
 Table 101. Raw Materials Key Suppliers
 Table 102. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 103. Milestones in Production Technology Evolution
 Table 104. Distributors List
 Table 105. Market Trends and Market Evolution
 Table 106. Market Drivers and Opportunities
 Table 107. Market Challenges, Risks, and Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources


List of Figures
 Figure 1. Endobronchial Blocker Product Picture
 Figure 2. Global Endobronchial Blocker Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. 5Fr Product Picture
 Figure 4. 7Fr Product Picture
 Figure 5. 9Fr Product Picture
 Figure 6. Global Endobronchial Blocker Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospital
 Figure 8. Clinic
 Figure 9. Others
 Figure 10. Endobronchial Blocker Report Years Considered
 Figure 11. Global Endobronchial Blocker Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Endobronchial Blocker Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Endobronchial Blocker Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Endobronchial Blocker Revenue Market Share by Region (2020-2031)
 Figure 15. Global Endobronchial Blocker Sales (2020-2031) & (Units)
 Figure 16. Global Endobronchial Blocker Sales (CAGR) by Region (2020-2031) (Units)
 Figure 17. Global Endobronchial Blocker Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Endobronchial Blocker Sales Volume Market Share in 2024
 Figure 19. Global Endobronchial Blocker Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. 5Fr Revenue Market Share by Manufacturer in 2024
 Figure 22. 7Fr Revenue Market Share by Manufacturer in 2024
 Figure 23. 9Fr Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Endobronchial Blocker Sales Market Share by Type (2020-2031)
 Figure 25. Global Endobronchial Blocker Revenue Market Share by Type (2020-2031)
 Figure 26. Global Endobronchial Blocker Sales Market Share by Application (2020-2031)
 Figure 27. Global Endobronchial Blocker Revenue Market Share by Application (2020-2031)
 Figure 28. North America Endobronchial Blocker Sales YoY (2020-2031) & (Units)
 Figure 29. North America Endobronchial Blocker Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Endobronchial Blocker Sales Revenue (US$ Million) in 2024
 Figure 31. North America Endobronchial Blocker Sales Volume (Units) by Type (2020- 2031)
 Figure 32. North America Endobronchial Blocker Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Endobronchial Blocker Sales Volume (Units) by Application (2020-2031)
 Figure 34. North America Endobronchial Blocker Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Endobronchial Blocker Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Endobronchial Blocker Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Endobronchial Blocker Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Endobronchial Blocker Sales YoY (2020-2031) & (Units)
 Figure 39. Europe Endobronchial Blocker Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Endobronchial Blocker Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Endobronchial Blocker Sales Volume (Units) by Type (2020-2031)
 Figure 42. Europe Endobronchial Blocker Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Endobronchial Blocker Sales Volume (Units) by Application (2020-2031)
 Figure 44. Europe Endobronchial Blocker Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Endobronchial Blocker Revenue (2020-2031) & (US$ Million)
 Figure 46. France Endobronchial Blocker Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Endobronchial Blocker Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Endobronchial Blocker Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Endobronchial Blocker Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Endobronchial Blocker Sales YoY (2020-2031) & (Units)
 Figure 51. Asia-Pacific Endobronchial Blocker Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Endobronchial Blocker Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Endobronchial Blocker Sales Volume (Units) by Type (2020- 2031)
 Figure 54. Asia-Pacific Endobronchial Blocker Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Endobronchial Blocker Sales Volume (Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Endobronchial Blocker Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Endobronchial Blocker Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Endobronchial Blocker Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Endobronchial Blocker Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Endobronchial Blocker Revenue (2020-2031) & (US$ Million)
 Figure 61. India Endobronchial Blocker Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Endobronchial Blocker Sales YoY (2020-2031) & (Units)
 Figure 63. Central and South America Endobronchial Blocker Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Endobronchial Blocker Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Endobronchial Blocker Sales Volume (Units) by Type (2021-2031)
 Figure 66. Central and South America Endobronchial Blocker Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Endobronchial Blocker Sales Volume (Units) by Application (2020-2031)
 Figure 68. Central and South America Endobronchial Blocker Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Endobronchial Blocker Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Endobronchial Blocker Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Endobronchial Blocker Sales YoY (2020-2031) & (Units)
 Figure 72. Middle East and Africa Endobronchial Blocker Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Endobronchial Blocker Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Endobronchial Blocker Sales Volume (Units) by Type (2021-2031)
 Figure 75. South America Endobronchial Blocker Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Endobronchial Blocker Sales Volume (Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Endobronchial Blocker Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Endobronchial Blocker Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Endobronchial Blocker Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Endobronchial Blocker Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Endobronchial Blocker Revenue (2020-2025) & (US$ Million)
 Figure 82. Endobronchial Blocker Industry Chain Mapping
 Figure 83. Regional Endobronchial Blocker Manufacturing Base Distribution (%)
 Figure 84. Global Endobronchial Blocker Production Market Share by Region (2020-2031)
 Figure 85. Endobronchial Blocker Production Process
 Figure 86. Regional Endobronchial Blocker Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed

以下、関連資料のご紹介